Asthma – Don't Forget To Breathe

Novel Drug Has Dual Action in Asthma, COPD

A novel inhaled drug appeared safe as a dual bronchodilator and anti-inflammatory in asthma and chronic obstructive pulmonary disease (COPD), a series of proof-of-concept studies showed. In COPD patients, nebulized RPL554 boosted forced expiratory volume in 1 second (FEV1) by 17% versus placebo, with peak effects comparable to inhaled beta-2 agonists, Clive P. Page, PhD,Continue reading “Novel Drug Has Dual Action in Asthma, COPD”